Trgovina Pfizer Inc - PFE CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.16 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.006402% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | -0.005927% | ||||||||
| Čas nočne pristojbine | 22:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Pfizer Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Ključni statistični podatki
| Predhodno. Zapri* | 44.18 |
| Odpri* | 44.18 |
| Enoletna sprememba* | -17.5% |
| Dnevni razpon* | 43.88 - 44.31 |
| Razpon 52 wk | 41.45-56.32 |
| Povprečni obseg (10 dni) | 27.90M |
| Povprečni obseg (3 meseci) | 449.19M |
| Tržna kapitalizacija | 247.32B |
| Razmerje P/E | 8.05 |
| Število delnic v obtoku | 5.61B |
| Prihodki | 100.33B |
| EPS | 5.47 |
| Dividenda (donosnost v %) | 3.7222 |
| Beta | 0.61 |
| Datum naslednjega zaslužka | May 1, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| Feb 3, 2023 | 44.02 | -0.25 | -0.56% | 44.27 | 44.40 | 43.83 |
| Feb 2, 2023 | 44.26 | 0.25 | 0.57% | 44.01 | 44.44 | 43.47 |
| Feb 1, 2023 | 44.01 | -0.20 | -0.45% | 44.21 | 44.24 | 43.39 |
| Jan 31, 2023 | 44.21 | 0.72 | 1.66% | 43.49 | 44.25 | 41.79 |
| Jan 30, 2023 | 43.49 | -0.11 | -0.25% | 43.60 | 44.11 | 43.29 |
| Jan 27, 2023 | 43.71 | -0.43 | -0.97% | 44.14 | 44.32 | 43.45 |
| Jan 26, 2023 | 44.14 | -1.00 | -2.22% | 45.14 | 45.19 | 43.60 |
| Jan 25, 2023 | 45.01 | 0.31 | 0.69% | 44.70 | 45.15 | 44.49 |
| Jan 24, 2023 | 44.71 | -0.26 | -0.58% | 44.97 | 45.01 | 43.99 |
| Jan 23, 2023 | 44.97 | -0.11 | -0.24% | 45.08 | 45.29 | 44.57 |
| Jan 20, 2023 | 44.99 | 0.00 | 0.00% | 44.99 | 45.41 | 44.70 |
| Jan 19, 2023 | 44.98 | 0.00 | 0.00% | 44.98 | 45.24 | 44.52 |
| Jan 18, 2023 | 45.04 | -1.00 | -2.17% | 46.04 | 46.28 | 44.92 |
| Jan 17, 2023 | 46.04 | -1.07 | -2.27% | 47.11 | 47.29 | 45.70 |
| Jan 13, 2023 | 47.72 | 0.10 | 0.21% | 47.62 | 48.13 | 46.99 |
| Jan 12, 2023 | 47.62 | 0.26 | 0.55% | 47.36 | 47.71 | 46.56 |
| Jan 11, 2023 | 47.36 | -0.28 | -0.59% | 47.64 | 47.80 | 46.81 |
| Jan 10, 2023 | 47.64 | -0.72 | -1.49% | 48.36 | 48.59 | 47.36 |
| Jan 9, 2023 | 48.39 | -2.28 | -4.50% | 50.67 | 50.70 | 48.27 |
| Jan 6, 2023 | 50.89 | 1.31 | 2.64% | 49.58 | 51.56 | 49.54 |
Pfizer Inc Events
| Time (UTC) | Country | Event |
|---|---|---|
| Monday, February 6, 2023 | ||
| Time (UTC) 13:30 | Country US
| Event Q4 2022 Pfizer Inc Earnings Release Q4 2022 Pfizer Inc Earnings ReleaseForecast -Previous - |
| Friday, April 28, 2023 | ||
| Time (UTC) 13:00 | Country US
| Event Pfizer Inc Annual Shareholders Meeting Pfizer Inc Annual Shareholders MeetingForecast -Previous - |
| Monday, May 1, 2023 | ||
| Time (UTC) 12:30 | Country US
| Event Q1 2023 Pfizer Inc Earnings Release Q1 2023 Pfizer Inc Earnings ReleaseForecast -Previous - |
| Thursday, May 18, 2023 | ||
| Time (UTC) 10:59 | Country IN
| Event Q4 2023 Pfizer Ltd Earnings Release Q4 2023 Pfizer Ltd Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Skupni prihodki | 52824 | 52546 | 40825 | 41172 | 41651 | 81288 |
| Prihodki | 52824 | 52546 | 40825 | 41172 | 41651 | 81288 |
| Celotni stroški prihodkov | 11925 | 10838 | 8872 | 8043 | 8405 | 30688 |
| Bruto dobiček | 40899 | 41708 | 31953 | 33129 | 33246 | 50600 |
| Celotni odhodki iz poslovanja | 43820 | 39557 | 36763 | 28841 | 33839 | 57636 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 14837 | 14784 | 12419 | 12485 | 11402 | 12256 |
| Raziskave in razvoj | 7872 | 7657 | 7713 | 7731 | 9340 | 11582 |
| Depreciation / Amortization | 4056 | 4758 | 4736 | 4462 | 3348 | 3700 |
| Nenavadni odhodki (prihodki) | 6058 | 2594 | 4675 | -2914 | 2619 | 3897 |
| Other Operating Expenses, Total | -928 | -1074 | -1652 | -966 | -1275 | -4487 |
| Prihodki iz poslovanja | 9004 | 12989 | 4062 | 12331 | 7812 | 23652 |
| Prihodki (odhodki) od obresti, neto Neoperativni | -824 | -972 | -538 | -877 | -538 | 560 |
| Gain (Loss) on Sale of Assets | 171 | 288 | 71 | 32 | -237 | 99 |
| Čisti dobiček pred obdavčitvijo | 8351 | 12305 | 3594 | 11485 | 7036 | 24311 |
| Čisti dobiček po davkih | 7228 | 11954 | 3264 | 10545 | 6666 | 22459 |
| Manjšinski delež | -31 | -47 | -36 | -29 | -36 | -45 |
| Čisti dobiček pred dodatnimi postavkami | 7197 | 11907 | 3228 | 10516 | 6630 | 22414 |
| Skupaj izredne postavke | 17 | 9402 | 7924 | 5757 | 2529 | -434 |
| Čisti dobiček | 7214 | 21309 | 11152 | 16273 | 9159 | 21980 |
| Total Adjustments to Net Income | 0 | -2 | 0 | -1 | 0 | -1 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 7197 | 11905 | 3228 | 10515 | 6630 | 22413 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 7214 | 21307 | 11152 | 16272 | 9159 | 21979 |
| Popravljen čisti dobiček | 7214 | 21307 | 11152 | 16272 | 9159 | 21979 |
| Popravljene ponderirane povprečne delnice | 6159 | 6058 | 5977 | 5675 | 5632 | 5708 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 1.16853 | 1.96517 | 0.54007 | 1.85286 | 1.1772 | 3.92659 |
| Dividends per Share - Common Stock Primary Issue | 1.2 | 1.28 | 1.36 | 1.44 | 1.52 | 1.56 |
| Popravljen normalizirani dobiček na enoto čistega dobička | 2.10748 | 2.31727 | 1.04885 | 1.22837 | 1.45366 | 4.09303 |
| Drugo, neto | -1 | -1 | -1 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 14516 | 18977 | 24094 | 23635 | 25661 |
| Prihodki | 14516 | 18977 | 24094 | 23635 | 25661 |
| Celotni stroški prihodkov | 4187 | 6986 | 9925 | 9611 | 10010 |
| Bruto dobiček | 10329 | 11991 | 14169 | 14024 | 15651 |
| Celotni odhodki iz poslovanja | 8989 | 13063 | 16447 | 19059 | 15788 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 2901 | 2794 | 2733 | 4069 | 2691 |
| Raziskave in razvoj | 2010 | 2270 | 2738 | 4565 | 2655 |
| Depreciation / Amortization | 858 | 931 | 981 | 916 | 835 |
| Nenavadni odhodki (prihodki) | -25 | 754 | 1613 | 1283 | 122 |
| Other Operating Expenses, Total | -942 | -672 | -1543 | -1385 | -525 |
| Prihodki iz poslovanja | 5527 | 5914 | 7647 | 4576 | 9873 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 127 | 637 | 190 | -394 | -823 |
| Gain (Loss) on Sale of Assets | 39 | 58 | 1 | 0 | 1 |
| Drugo, neto | -1 | -2 | 1 | -1 | |
| Čisti dobiček pred obdavčitvijo | 5692 | 6609 | 7836 | 4183 | 9050 |
| Čisti dobiček po davkih | 4884 | 5566 | 8167 | 3849 | 7878 |
| Manjšinski delež | -9 | -26 | -12 | 2 | -6 |
| Čisti dobiček pred dodatnimi postavkami | 4875 | 5540 | 8155 | 3851 | 7872 |
| Skupaj izredne postavke | 1 | 24 | -9 | -458 | -9 |
| Čisti dobiček | 4876 | 5564 | 8146 | 3393 | 7863 |
| Total Adjustments to Net Income | 1 | -1 | 1 | ||
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | 4876 | 5539 | 8155 | 3851 | 7873 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | 4877 | 5563 | 8146 | 3393 | 7864 |
| Popravljen čisti dobiček | 4877 | 5563 | 8146 | 3393 | 7864 |
| Popravljene ponderirane povprečne delnice | 5662 | 5678 | 5725 | 5768 | 5758 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | 0.86118 | 0.97552 | 1.42445 | 0.66765 | 1.36732 |
| Dividends per Share - Common Stock Primary Issue | 0.39 | 0.39 | 0.39 | 0.39 | 0.4 |
| Popravljen normalizirani dobiček na enoto čistega dobička | 0.82179 | 1.06851 | 1.40629 | 0.74896 | 1.31052 |
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 38949 | 41141 | 49926 | 32803 | 35067 | 59693 |
| Denarna sredstva in kratkoročne naložbe | 17850 | 19992 | 18833 | 9646 | 12221 | 31069 |
| Denarna sredstva in ustrezniki | 2595 | 1342 | 1139 | 1121 | 1784 | 1944 |
| Kratkoročne naložbe | 15255 | 18650 | 17694 | 8525 | 10437 | 29125 |
| Celotne terjatve, neto | 8225 | 8221 | 8025 | 6772 | 7930 | 11479 |
| Accounts Receivable - Trade, Net | 8225 | 8221 | 8025 | 6772 | 7930 | 11479 |
| Total Inventory | 6783 | 7578 | 7508 | 7068 | 8046 | 9059 |
| Other Current Assets, Total | 6091 | 5350 | 15560 | 9317 | 6870 | 8086 |
| Total Assets | 171615 | 171797 | 159422 | 167594 | 154229 | 181476 |
| Property/Plant/Equipment, Total - Net | 13318 | 13865 | 13385 | 14258 | 15293 | 17721 |
| Property/Plant/Equipment, Total - Gross | 28125 | 30037 | 29977 | 29248 | 30104 | 32794 |
| Accumulated Depreciation, Total | -14807 | -16172 | -16591 | -14990 | -14812 | -15074 |
| Goodwill, Net | 54449 | 55952 | 53411 | 48202 | 49577 | 49208 |
| Intangibles, Net | 52648 | 48741 | 35211 | 33936 | 28471 | 25146 |
| Long Term Investments | 7116 | 7015 | 2767 | 20147 | 20262 | 21526 |
| Other Long Term Assets, Total | 5135 | 5083 | 4722 | 18248 | 5559 | 8182 |
| Total Current Liabilities | 31115 | 30427 | 31858 | 37304 | 25920 | 42671 |
| Accounts Payable | 4536 | 4656 | 4674 | 3887 | 4309 | 5578 |
| Accrued Expenses | 2487 | 2196 | 2397 | 2659 | 3379 | 3781 |
| Notes Payable/Short Term Debt | 6463 | 6407 | 4055 | 14733 | 701 | 605 |
| Current Port. of LT Debt/Capital Leases | 4225 | 3546 | 4776 | 1462 | 2002 | 1636 |
| Other Current Liabilities, Total | 13404 | 13622 | 15956 | 14563 | 15529 | 31071 |
| Total Liabilities | 112071 | 100489 | 96015 | 104450 | 90991 | 104276 |
| Total Long Term Debt | 31398 | 33538 | 32909 | 35955 | 37133 | 36195 |
| Long Term Debt | 31398 | 33538 | 32909 | 35955 | 37133 | 36195 |
| Deferred Income Tax | 30753 | 3900 | 3700 | 5652 | 4063 | 349 |
| Minority Interest | 296 | 348 | 351 | 303 | 235 | 262 |
| Other Liabilities, Total | 18509 | 32276 | 27197 | 25236 | 23640 | 24799 |
| Total Equity | 59544 | 71308 | 63407 | 63144 | 63238 | 77200 |
| Preferred Stock - Non Redeemable, Net | 24 | 21 | 19 | 17 | 0 | |
| Common Stock | 461 | 464 | 467 | 468 | 470 | 473 |
| Additional Paid-In Capital | 82685 | 84278 | 86253 | 87428 | 88674 | 90591 |
| Retained Earnings (Accumulated Deficit) | 71774 | 85291 | 89554 | 97670 | 96770 | 103394 |
| Treasury Stock - Common | -84364 | -89425 | -101610 | -110801 | -110988 | -111361 |
| Unrealized Gain (Loss) | -131 | 401 | -68 | -35 | 116 | -220 |
| Other Equity, Total | -10905 | -9722 | -11208 | -11603 | -11804 | -5677 |
| Total Liabilities & Shareholders’ Equity | 171615 | 171797 | 159422 | 167594 | 154229 | 181476 |
| Total Common Shares Outstanding | 6070 | 5979 | 5717 | 5534 | 5567 | 5620 |
| Total Preferred Shares Outstanding | 0.0006 | 0.00052 | 0.00048 | 0.00043 | 0 | 0 |
| Apr 2021 | Jul 2021 | Oct 2021 | Dec 2021 | Apr 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 39533 | 48814 | 57900 | 59693 | 54420 |
| Denarna sredstva in kratkoročne naložbe | 13667 | 21700 | 29696 | 31069 | 23897 |
| Denarna sredstva in ustrezniki | 1768 | 2372 | 1966 | 1944 | 2470 |
| Kratkoročne naložbe | 11899 | 19328 | 27730 | 29125 | 21427 |
| Celotne terjatve, neto | 9864 | 10587 | 11897 | 11479 | 13225 |
| Accounts Receivable - Trade, Net | 9864 | 10587 | 11897 | 11479 | 13225 |
| Total Inventory | 8493 | 8948 | 8640 | 9059 | 9979 |
| Other Current Assets, Total | 7509 | 7579 | 7667 | 8086 | 7319 |
| Total Assets | 158818 | 169920 | 179188 | 181476 | 183841 |
| Property/Plant/Equipment, Total - Net | 14011 | 14224 | 14436 | 14882 | 15109 |
| Property/Plant/Equipment, Total - Gross | 29116 | 29552 | 29839 | 29955 | 30467 |
| Accumulated Depreciation, Total | -15105 | -15328 | -15403 | -15074 | -15358 |
| Goodwill, Net | 49791 | 49867 | 49489 | 49208 | 50211 |
| Intangibles, Net | 27974 | 27323 | 26306 | 25146 | 29816 |
| Long Term Investments | 20228 | 20942 | 21597 | 21526 | 20737 |
| Other Long Term Assets, Total | 7281 | 8750 | 9460 | 11021 | 13548 |
| Total Current Liabilities | 26652 | 35664 | 41803 | 42671 | 39268 |
| Accounts Payable | 4064 | 4327 | 4698 | 5578 | 5506 |
| Accrued Expenses | 1985 | 2015 | 2571 | 3332 | 2249 |
| Notes Payable/Short Term Debt | 676 | 201 | 966 | 605 | 385 |
| Current Port. of LT Debt/Capital Leases | 3676 | 3687 | 2663 | 1636 | 260 |
| Other Current Liabilities, Total | 16251 | 25434 | 30905 | 31520 | 30868 |
| Total Liabilities | 90198 | 99878 | 103496 | 104276 | 101417 |
| Total Long Term Debt | 35347 | 35354 | 36250 | 36195 | 35656 |
| Long Term Debt | 35347 | 35354 | 36250 | 36195 | 35656 |
| Deferred Income Tax | 4355 | 4161 | 328 | 349 | 655 |
| Minority Interest | 245 | 273 | 275 | 262 | 261 |
| Other Liabilities, Total | 23599 | 24426 | 24840 | 24799 | 25577 |
| Total Equity | 68620 | 70042 | 75692 | 77200 | 82424 |
| Common Stock | 472 | 472 | 473 | 473 | 476 |
| Additional Paid-In Capital | 89002 | 89336 | 89973 | 90591 | 90844 |
| Retained Earnings (Accumulated Deficit) | 95158 | 96346 | 102252 | 103394 | 111193 |
| Treasury Stock - Common | -111349 | -111356 | -111359 | -111361 | -113931 |
| Unrealized Gain (Loss) | -26 | 79 | -146 | -220 | -133 |
| Other Equity, Total | -4637 | -4835 | -5501 | -5677 | -6025 |
| Total Liabilities & Shareholders’ Equity | 158818 | 169920 | 179188 | 181476 | 183841 |
| Total Common Shares Outstanding | 5594 | 5599 | 5611 | 5620 | 5591 |
| Total Preferred Shares Outstanding | 0 |
- Letni
- Četrtletno
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | 7246 | 21355 | 11188 | 16302 | 9652 | 22025 |
| Denarna sredstva iz poslovanja | 16193 | 16802 | 15827 | 12587 | 14403 | 32580 |
| Denarna sredstva iz poslovanja | 5757 | 6269 | 6384 | 6010 | 4777 | 5191 |
| Deferred Taxes | -700 | -2410 | -2205 | 614 | -1468 | -4293 |
| Nedenarne postavke | 3791 | -9748 | 1387 | -6307 | 1717 | -3147 |
| Cash Taxes Paid | 2521 | 2489 | 3655 | 3664 | 3153 | 7427 |
| Denarna sredstva Plačane obresti | 1451 | 1518 | 1311 | 1587 | 1641 | 1467 |
| Spremembe v obratnem kapitalu | 99 | 1336 | -927 | -4032 | -275 | 12804 |
| Denarna sredstva pri naložbenju | -7791 | -4740 | 4525 | -3945 | -4271 | -22546 |
| Kapitalski izdatki | -1999 | -2217 | -2196 | -2594 | -2791 | -2711 |
| Celotne druge postavke denarnih tokov pri naložbenju | -5792 | -2523 | 6721 | -1351 | -1480 | -19835 |
| Denarna sredstva pri financiranju | -9228 | -13350 | -20441 | -8485 | -9649 | -9816 |
| Postavke denarnega toka pri financiranju | -536 | -612 | -589 | -735 | 11121 | 16 |
| Total Cash Dividends Paid | -7317 | -7659 | -7978 | -8043 | -8440 | -8729 |
| Izdaja (odplačilo) delnic, neto | -3981 | -4138 | -10939 | -8471 | 425 | 0 |
| Izdaja (odplačilo) dolga, neto | 2606 | -941 | -935 | 8764 | -12755 | -1103 |
| Učinki deviznih tečajev | -215 | 53 | -116 | -32 | -8 | -59 |
| Neto sprememba denarnih sredstev | -1041 | -1235 | -205 | 125 | 475 | 159 |
| Apr 2021 | Jul 2021 | Oct 2021 | Dec 2021 | Apr 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 4886 | 10475 | 18633 | 22025 | 7870 |
| Cash From Operating Activities | 4539 | 15836 | 26666 | 32580 | 6541 |
| Cash From Operating Activities | 1226 | 2554 | 3914 | 5191 | 1187 |
| Deferred Taxes | 199 | -3702 | -4293 | -2321 | |
| Non-Cash Items | -446 | -1590 | -2997 | -3147 | 537 |
| Cash Taxes Paid | 394 | 2188 | 2943 | 7427 | 354 |
| Cash Interest Paid | 445 | 798 | 1205 | 1467 | 453 |
| Changes in Working Capital | -1326 | 4397 | 10818 | 12804 | -732 |
| Cash From Investing Activities | -1747 | -9884 | -19960 | -22546 | 567 |
| Capital Expenditures | -554 | -1094 | -1718 | -2711 | -643 |
| Other Investing Cash Flow Items, Total | -1193 | -8790 | -18242 | -19835 | 1210 |
| Cash From Financing Activities | -2807 | -5364 | -6465 | -9816 | -6578 |
| Financing Cash Flow Items | -610 | -510 | -185 | 16 | -500 |
| Total Cash Dividends Paid | -2172 | -4355 | -6540 | -8729 | -2249 |
| Issuance (Retirement) of Debt, Net | -25 | -499 | 260 | -1103 | -1829 |
| Foreign Exchange Effects | 0 | 5 | -32 | -59 | -1 |
| Net Change in Cash | -15 | 593 | 209 | 159 | 529 |
| Issuance (Retirement) of Stock, Net | 0 | -2000 |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7471 | 491001204 | 5107541 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 5.1238 | 287612741 | 395713 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.0984 | 286187374 | 1836743 | 2022-09-30 | LOW |
| Capital World Investors | Investment Advisor | 4.4332 | 248850529 | -1276218 | 2022-09-30 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 3.7567 | 210874152 | -8297495 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9675 | 110442140 | 1859302 | 2022-09-30 | LOW |
| Charles Schwab Investment Management, Inc. | Investment Advisor | 1.2492 | 70123906 | 6001894 | 2022-09-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0112 | 56763604 | 200794 | 2021-12-31 | LOW |
| Capital International Investors | Investment Advisor | 0.9856 | 55323878 | 5892896 | 2022-09-30 | LOW |
| State Farm Insurance Companies | Insurance Company | 0.9543 | 53568997 | 0 | 2022-09-30 | LOW |
| BofA Global Research (US) | Research Firm | 0.803 | 45074753 | -582392 | 2022-09-30 | LOW |
| Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7631 | 42832953 | -453753 | 2022-09-30 | LOW |
| Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7449 | 41814509 | -977163 | 2022-09-30 | LOW |
| Morgan Stanley Smith Barney LLC | Investment Advisor | 0.7363 | 41330356 | 393541 | 2022-09-30 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.7347 | 41242414 | 1009399 | 2022-09-30 | LOW |
| MFS Investment Management | Investment Advisor/Hedge Fund | 0.7287 | 40906577 | -874608 | 2022-09-30 | LOW |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.6492 | 36441408 | 1403401 | 2022-09-30 | LOW |
| BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.632 | 35478928 | -2969100 | 2022-09-30 | LOW |
| T. Rowe Price Associates, Inc. | Investment Advisor | 0.5195 | 29162770 | -5775440 | 2022-09-30 | LOW |
| Mellon Investments Corporation | Investment Advisor/Hedge Fund | 0.5151 | 28915413 | -87396 | 2022-09-30 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group +485000+
Borzni posredniki
65000+
Aktivne stranke mesečno
$48000000+
Mesečni obseg naložb
$28000000+
Preizkusi zdaj Dvigi vsak mesec
Kalkulator trgovanja
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trgovalna provizija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Vzvod
20:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Pfizer Company profile
O družbi Pfizer Inc
Pfizer Inc. (Pfizer) je svetovno biofarmacevtsko podjetje, ki temelji na raziskavah. Podjetje se ukvarja z odkrivanjem, razvojem, proizvodnjo, trženjem, prodajo in distribucijo biofarmacevtskih izdelkov. Njen globalni portfelj vključuje zdravila in cepiva. Podjetje ponuja terapevtske kandidate na področju gastroenterologije, dermatologije in kardiologije, vključno z etrasimodom, peroralnim selektivnim modulatorjem receptorjev sfingozin-1-fosfata (S1P), ki ga razvija za vrsto imunovnetnih bolezni, kot so ulcerozni kolitis, Crohnova bolezen, atopijski dermatitis, eozinofilni ezofagitis in alopecija areata. Družba deluje na različnih trgih za razvoj dobrega počutja, preprečevanja, zdravljenja in zdravil. Sodeluje z izvajalci zdravstvenih storitev, vladami in lokalnimi skupnostmi, da bi podprla in zagotovila dostop do zdravstvenega varstva. Zdravila in cepiva družbe zagotavljajo vrednost za ponudnike zdravstvenih storitev in bolnike z zdravljenjem bolezni, izboljšanjem zdravja in dobrega počutja.
| Industry: | Pharmaceuticals (NEC) |
235 E 42nd St
NEW YORK
NEW YORK 10017
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 485.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com